However, this effect was partially diminished by co‐treatment with recombinant CTGF protein (Figure 5I), suggesting that miR‐302c may play a protective role in MMT of HPMCs and peritoneal fibrosis through CTGF. This evidence concerns the gene CCN2 and Peritoneal Fibrosis.